{"id":"W2887131751","doi":"10.18632/oncotarget.25739","title":"Dual targeting of HER2-positive breast cancer with trastuzumab emtansine and pertuzumab: understanding clinical trial results","year":2018,"lang":"en","type":"review","venue":"Oncotarget","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Pertuzumab; Trastuzumab; Trastuzumab emtansine; Medicine; Oncology; Breast cancer; Internal medicine; Cancer; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00273115,0.000749406,0.003958046,0.0003294019,0.0001853402,0.00006267225,0.000256975,0.0007334349,0.0003313832],"category_scores_gemma":[0.0007954321,0.0005170975,0.0005634219,0.0007091197,0.001112999,0.00011053,0.0001919046,0.001531191,0.00002205589],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002005815,"about_ca_system_score_gemma":0.005640742,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005292562,"about_ca_topic_score_gemma":0.0002241889,"domain_scores_codex":[0.9936515,0.0007774751,0.002196258,0.001307263,0.001229574,0.000837911],"domain_scores_gemma":[0.9957477,0.001484674,0.001040924,0.0006794203,0.0004754892,0.0005717517],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.2377774,0.003054001,0.001439127,0.08011278,0.008143893,0.002802974,0.002458948,0.000001779179,0.000007793486,0.0003310789,0.1619912,0.501879],"study_design_scores_gemma":[0.04732936,0.009518679,0.0002524505,0.07237812,0.002926998,0.0008142128,0.0004394138,0.00003285638,0.000003581622,0.00002650965,0.8653889,0.0008889572],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001010948,0.9879649,0.00008794913,0.0008637338,0.0009146065,0.003424013,0.00231546,0.00007418771,0.003344246],"genre_scores_gemma":[0.001302334,0.9918129,0.0009825764,0.00007787837,0.00414801,0.0001315226,0.0004532195,0.0002071414,0.000884368],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7033977,"threshold_uncertainty_score":0.9999964,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2599617239256731,"score_gpt":0.4952517428112211,"score_spread":0.235290018885548,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}